New funding will support development of personalized cell therapies for compromised patient populations
A Biomedical Catalyst Primer Award will fund research into low transfection efficient in patients with already highly compromised cell populations.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.